The antidepressant-like effect and proposed mechanism of action of TPN672MA, a novel serotonin-dopamine receptor modulator for the treatment of schizophrenia
0
Authors
Jiaxin Cheng
Jiaxin Cheng•Chunhui Wu•Jingshan Shen
Published
June 25, 2024
Abstract
TPN672MA, an innovative antipsychotic drug candidate currently in clinical trials, acts as a dopamine D
